Poland
· Delayed Price · Currency is PLN Genomed Spólka Akcyjna Statistics
Total Valuation
WSE:GEN has a market cap or net worth of PLN 32.24 million. The enterprise value is 27.00 million.
| Market Cap | 32.24M |
| Enterprise Value | 27.00M |
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
WSE:GEN has 1.32 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 1.32M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 44.76% |
| Owned by Institutions (%) | n/a |
| Float | 41,650 |
Valuation Ratios
The trailing PE ratio is 29.09.
| PE Ratio | 29.09 |
| Forward PE | n/a |
| PS Ratio | 1.40 |
| PB Ratio | 2.92 |
| P/TBV Ratio | 2.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 19.66 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.88, with an EV/FCF ratio of -1,000.40.
| EV / Earnings | 24.36 |
| EV / Sales | 1.17 |
| EV / EBITDA | 13.88 |
| EV / EBIT | 22.48 |
| EV / FCF | -1,000.40 |
Financial Position
The company has a current ratio of 6.28
| Current Ratio | 6.28 |
| Quick Ratio | 4.82 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 4,637.09 |
Financial Efficiency
Return on equity (ROE) is 10.50% and return on invested capital (ROIC) is 7.11%.
| Return on Equity (ROE) | 10.50% |
| Return on Assets (ROA) | 6.01% |
| Return on Invested Capital (ROIC) | 7.11% |
| Return on Capital Employed (ROCE) | 10.55% |
| Revenue Per Employee | 479,310 |
| Profits Per Employee | 23,092 |
| Employee Count | 48 |
| Asset Turnover | 1.84 |
| Inventory Turnover | 4.10 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.57% in the last 52 weeks. The beta is 0.04, so WSE:GEN's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | -17.57% |
| 50-Day Moving Average | 26.64 |
| 200-Day Moving Average | 29.01 |
| Relative Strength Index (RSI) | 30.22 |
| Average Volume (20 Days) | 86 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, WSE:GEN had revenue of PLN 23.01 million and earned 1.11 million in profits. Earnings per share was 0.84.
| Revenue | 23.01M |
| Gross Profit | 14.49M |
| Operating Income | 1.20M |
| Pretax Income | 1.21M |
| Net Income | 1.11M |
| EBITDA | 1.95M |
| EBIT | 1.20M |
| Earnings Per Share (EPS) | 0.84 |
Balance Sheet
The company has 5.24 million in cash and n/a in debt, giving a net cash position of 5.24 million or 3.97 per share.
| Cash & Cash Equivalents | 5.24M |
| Total Debt | n/a |
| Net Cash | 5.24M |
| Net Cash Per Share | 3.97 |
| Equity (Book Value) | 11.04M |
| Book Value Per Share | 8.36 |
| Working Capital | 7.73M |
Cash Flow
In the last 12 months, operating cash flow was 1.64 million and capital expenditures -1.67 million, giving a free cash flow of -26,986.
| Operating Cash Flow | 1.64M |
| Capital Expenditures | -1.67M |
| Free Cash Flow | -26,986 |
| FCF Per Share | -0.02 |
Margins
Gross margin is 62.99%, with operating and profit margins of 5.22% and 4.82%.
| Gross Margin | 62.99% |
| Operating Margin | 5.22% |
| Pretax Margin | 5.26% |
| Profit Margin | 4.82% |
| EBITDA Margin | 8.45% |
| EBIT Margin | 5.22% |
| FCF Margin | n/a |
Dividends & Yields
WSE:GEN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 3.44% |
| FCF Yield | -0.08% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
WSE:GEN has an Altman Z-Score of 16.4.
| Altman Z-Score | 16.4 |
| Piotroski F-Score | n/a |